PULMONX CORPORATION Gross Profit
PULMONX CORPORATION (LUNG) reported Gross Profit of $17.74 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement
us-gaap:GrossProfit · last filed 2026-08-04
- PULMONX CORPORATION gross profit for the quarter ending 2026-06-30 was $17.74M, a 3.13% increase year-over-year.
- PULMONX CORPORATION gross profit for the quarter ending 2026-03-31 was $16.04M, a 1.82% decline year-over-year.
- PULMONX CORPORATION gross profit for the quarter ending 2025-12-31 was $17.54M, a 0.28% decline year-over-year.
- PULMONX CORPORATION gross profit for the quarter ending 2025-09-30 was $16.05M, a 6.83% increase year-over-year.
- PULMONX CORPORATION gross profit for fiscal 2025 was $67.14M, a 8.29% increase from fiscal 2024.
- PULMONX CORPORATION gross profit for fiscal 2024 was $62.00M, a 22.16% increase from fiscal 2023.
- PULMONX CORPORATION gross profit for fiscal 2023 was $50.75M, a 27.31% increase from fiscal 2022.
- PULMONX CORPORATION gross profit for fiscal 2022 was $39.87M, a 11.89% increase from fiscal 2021.
| Period end | Gross Profit 3 month | Gross Profit 6 month | Gross Profit 9 month | Gross Profit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $17.74M 10-Q · filed 2026-08-04 | $33.79M 10-Q · filed 2026-08-04 | $51.33M derived: sum of 3 quarters · filed 2026-08-04 | $67.38M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $16.04M 10-Q · filed 2026-05-04 | $33.59M derived: sum of 2 quarters · filed 2026-05-04 | $49.64M derived: sum of 3 quarters · filed 2026-05-04 | $66.84M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $17.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $33.59M derived: sum of 2 quarters · filed 2026-03-10 | $50.80M derived: sum of 3 quarters · filed 2026-08-04 | $67.14M 10-K · filed 2026-03-10 |
| 2025-09-30 | $16.05M 10-Q · filed 2025-11-12 | $33.26M derived: sum of 2 quarters · filed 2026-08-04 | $49.60M 10-Q · filed 2025-11-12 | $67.19M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $17.20M 10-Q · filed 2026-08-04 | $33.55M 10-Q · filed 2026-08-04 | $51.14M derived: sum of 3 quarters · filed 2026-08-04 | $66.16M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $16.34M 10-Q · filed 2026-05-04 | $33.93M derived: sum of 2 quarters · filed 2026-05-04 | $48.96M derived: sum of 3 quarters · filed 2026-05-04 | $64.27M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $17.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $32.62M derived: sum of 2 quarters · filed 2026-03-10 | $47.92M derived: sum of 3 quarters · filed 2026-03-10 | $62.00M 10-K · filed 2026-03-10 |
| 2024-09-30 | $15.03M 10-Q · filed 2025-11-12 | $30.33M derived: sum of 2 quarters · filed 2025-11-12 | $44.41M 10-Q · filed 2025-11-12 | $58.81M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $15.31M 10-Q · filed 2025-08-01 | $29.39M 10-Q · filed 2025-08-01 | $43.78M derived: sum of 3 quarters · filed 2025-08-01 | $56.81M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $14.08M 10-Q · filed 2025-05-02 | $28.48M derived: sum of 2 quarters · filed 2025-05-02 | $41.51M derived: sum of 3 quarters · filed 2025-05-02 | $54.24M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $14.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $27.43M derived: sum of 2 quarters · filed 2025-02-25 | $40.16M derived: sum of 3 quarters · filed 2025-02-25 | $50.75M 10-K · filed 2025-02-25 |
| 2023-09-30 | $13.03M 10-Q · filed 2024-11-01 | $25.76M derived: sum of 2 quarters · filed 2024-11-01 | $36.35M 10-Q · filed 2024-11-01 | $47.54M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $12.73M 10-Q · filed 2024-08-02 | $23.32M 10-Q · filed 2024-08-02 | $34.51M derived: sum of 3 quarters · filed 2024-08-02 | $44.66M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $10.59M 10-Q · filed 2024-05-03 | $21.77M derived: sum of 2 quarters · filed 2024-05-03 | $31.93M derived: sum of 3 quarters · filed 2024-05-03 | $42.34M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $11.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $21.34M derived: sum of 2 quarters · filed 2024-02-27 | $31.75M derived: sum of 3 quarters · filed 2024-02-27 | $39.87M 10-K · filed 2024-02-27 |
| 2022-09-30 | $10.15M 10-Q · filed 2023-11-03 | $20.57M derived: sum of 2 quarters · filed 2023-11-03 | $28.68M 10-Q · filed 2023-11-03 | $38.93M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $10.42M 10-Q · filed 2023-08-04 | $18.53M 10-Q · filed 2023-08-04 | $28.78M derived: sum of 3 quarters · filed 2023-08-04 | $38.52M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $8.11M 10-Q · filed 2023-05-08 | $18.36M derived: sum of 2 quarters · filed 2023-05-08 | $28.10M derived: sum of 3 quarters · filed 2023-05-08 | $37.13M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $10.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $19.99M derived: sum of 2 quarters · filed 2023-03-01 | $29.02M derived: sum of 3 quarters · filed 2023-03-01 | $35.63M 10-K · filed 2023-03-01 |
| 2021-09-30 | $9.74M 10-Q · filed 2022-11-08 | $18.77M derived: sum of 2 quarters · filed 2022-11-08 | $25.38M 10-Q · filed 2022-11-08 | $32.46M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $9.03M 10-Q · filed 2022-08-08 | $15.64M 10-Q · filed 2022-08-08 | $22.72M derived: sum of 3 quarters · filed 2022-08-08 | $30.18M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $6.61M 10-Q · filed 2022-05-09 | $13.69M derived: sum of 2 quarters · filed 2022-05-09 | $21.15M derived: sum of 3 quarters · filed 2022-05-09 | $22.16M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $7.08M 10-K · filed 2021-03-15 | $14.54M derived: sum of 2 quarters · filed 2021-11-09 | $15.55M derived: sum of 3 quarters · filed 2021-11-09 | $21.20M 10-K · filed 2022-03-01 |
| 2020-09-30 | $7.46M 10-Q · filed 2021-11-09 | $8.47M derived: sum of 2 quarters · filed 2021-11-09 | $14.12M 10-Q · filed 2021-11-09 | $21.46M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $1.01M 10-Q · filed 2021-08-10 | $6.66M 10-Q · filed 2021-08-10 | $14.00M derived: sum of 3 quarters · filed 2021-08-10 | $20.41M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $5.65M 10-Q · filed 2021-05-12 | $12.99M derived: sum of 2 quarters · filed 2021-05-12 | $19.39M derived: sum of 3 quarters · filed 2021-05-12 | $24.35M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $7.34M 10-K · filed 2021-03-15 | $13.74M derived: sum of 2 quarters · filed 2021-03-15 | $18.70M derived: sum of 3 quarters · filed 2021-03-15 | $22.41M 10-K · filed 2021-03-15 |
| 2019-09-30 | $6.41M 10-K · filed 2021-03-15 | $11.36M derived: sum of 2 quarters · filed 2021-03-15 | $15.08M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $4.95M 10-K · filed 2021-03-15 | $8.67M derived: sum of 2 quarters · filed 2021-03-15 | ||
| 2019-03-31 | $3.72M 10-K · filed 2021-03-15 | |||
| 2018-12-31 | $12.29M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |